Truist Financial Corp Atai Life Sciences N.V. Transaction History
Truist Financial Corp
- $71.8 Billion
- Q3 2025
A detailed history of Truist Financial Corp transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Truist Financial Corp holds 16,394 shares of ATAI stock, worth $71,477. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,394
Previous 12,296
33.33%
Holding current value
$71,477
Previous $26,000
230.77%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ATAI
# of Institutions
122Shares Held
33.3MCall Options Held
494KPut Options Held
315K-
Ubs Group Ag7.7MShares$33.6 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$23.7 Million0.02% of portfolio
-
Morgan Stanley New York, NY3.49MShares$15.2 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.64MShares$11.5 Million0.59% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$5.7 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $723M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...